Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Magnetic Resonance Imaging × Clear all

Status

Recruiting 6 Unknown 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Head and Neck Neoplasms 4 Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Thyroid Nodule 1 Spinal Cord Tumor of Cervical Spine 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Retinoblastoma 1 Pathologic Complete Response 1 Parotid Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Multiple Pulmonary Nodules 1 Mouth Neoplasms 1 Lymphoma 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Disease 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Calcinosis 1 Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 71 Fluorouracil 25 Oxaliplatin 22 130-nm albumin-bound paclitaxel 21 Leucovorin 15 Capecitabine 15 S 1 (combination) 14 Albumin-Bound Paclitaxel 14 Taxes 10 folfirinox 9 Radiosurgery 9 Irinotecan 9 pembrolizumab 7 Radiotherapy 7 Drug Therapy 6 Cisplatin 6 irinotecan sucrosofate 5 Pancreaticoduodenectomy 5 Injections 5 Docetaxel 5 apatinib 4 Radiofrequency Ablation 4 Radiation 4 Paclitaxel 4 Blood Specimen Collection 4 Biopsy 4 tislelizumab 3 rubitecan 3 camrelizumab 3 Stents 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04883450 2024-01-16

PRO-TECT

Kaiser Permanente

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡